Ophthalmology · Palm Beach Gardens, FL
NPI
1932171147
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3502 Kyoto Gardens Dr Ste B
Palm Beach Gardens, FL, 33410
Phone (561) 630-7120
Groups this clinician bills Medicare through
Medicare paid, 2024
$452K
5,639 services
Medicare patients, 2024
1,503
Average age 77
Drug cost, 2024
$1.6M
4,647 prescriptions
Company payments, 2025
$302K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark S Milner was code 99214 (office e&m - established), 2,923 times for 1,267 patients. In total Mark S Milner billed 5,639 services in 46 codes, and Medicare paid $452K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,923 | 1,267 | $94.86 | $277K |
| 83861 Clinical Chemistry | Office | 440 | 192 | $22.03 | $9,693 |
| 68761 Eye | Office | 288 | 88 | $85.34 | $25K |
| 92133 Computerized Ophthalmic Imaging | Office | 276 | 224 | $25.75 | $7,106 |
| 99204 Office E&M - New | Office | 267 | 267 | $123.29 | $33K |
| 92083 Vision, Hearing, and Speech Services | Office | 250 | 224 | $46.19 | $12K |
| 99213 Office E&M - Established | Office | 212 | 123 | $67.61 | $14K |
| 92250 Angiography | Office | 140 | 135 | $27.80 | $3,892 |
| 92020 Ophthalmological E&M | Office | 134 | 96 | $19.57 | $2,622 |
| 92134 Computerized Ophthalmic Imaging | Office | 132 | 116 | $28.70 | $3,788 |
| 67820 Eye | Office | 80 | 36 | $13.74 | $1,099 |
| 76514 Ultrasound - Nonspecific | Office | 64 | 44 | $9.06 | $580 |
| 92014 Ophthalmological E&M | Office | 46 | 42 | $92.96 | $4,276 |
| 68801 Eye | Office | 44 | 13 | $49.36 | $2,172 |
| 66821 Cataract Surgery | Office | 37 | 31 | $247.57 | $9,160 |
By year: 2022 $389K for 4,261 services; 2023 $470K for 6,368 services; 2024 $452K for 5,639 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 440 | 192 | $22.03 | $9,693 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark S Milner prescribed most often to Medicare patients was Erythromycin (Erythromycin Base), with 980 prescriptions and refills. In total Mark S Milner wrote 4,647 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Erythromycin Erythromycin Base | 980 | 1,025 | 572 | $10K |
| Restasis Cyclosporine | 605 | 773 | 265 | $470K |
| Prednisolone Acetate Generic | 474 | 656 | 202 | $23K |
| Moxifloxacin Moxifloxacin Hcl | 257 | 259 | 104 | $4,149 |
| Brimonidine Tartrate Generic | 235 | 437 | 81 | $5,153 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 200 | 228 | 157 | $9,869 |
| Bacitracin-Polymyxin Bacitracin/Polymyxin B Sulfate | 185 | 187 | 107 | $2,295 |
| Miebo Perfluorohexyloctane/Pf | 151 | 191 | 49 | $122K |
| Xiidra Lifitegrast | 133 | 178 | 40 | $119K |
| Latanoprost Generic | 124 | 231 | 43 | $1,076 |
| Cequa Cyclosporine | 111 | 137 | 52 | $78K |
| Cyclosporine Generic | 108 | 148 | 51 | $37K |
| Valacyclovir Valacyclovir Hcl | 103 | 145 | 30 | $6,086 |
| Timolol Maleate Generic | 90 | 164 | 28 | $1,775 |
| Dorzolamide Hcl Generic | 75 | 150 | 24 | $1,197 |
Brand drugs: - claims; generic drugs: 2,510 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark S Milner $302K ($302K in general payments such as food, travel and fees) from 17 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $93K.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 53 | $93K |
| Bausch & Lomb Americas Inc. BLCO | 75 | $89K |
| Alcon Vision LLC ALC | 38 | $58K |
| Biotissue Holdings Inc. | 12 | $23K |
| Abbvie Inc. ABBV | 15 | $14K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 13 | $13K |
| Alcon Research LLC ALC | 3 | $8,500 |
| Oyster Point Pharma, Inc. | 8 | $1,024 |
| Harrow Eye, LLC | 14 | $705 |
| Glaukos Corporation GKOS | 7 | $317 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.